Anti–SARS-CoV-2 Antibody Responses in Patients With IBD Treated With Biologics: Are We Finding CLARITY?

por Chapman, Thomas P., Revés, Joana, Torres, Joana, Satsangi, Jack
Publicado 2021

Endoscopic characterization of neoplastic and non-neoplastic lesions in inflammatory bowel disease: systematic review in the era of advanced endoscopic imaging

por Cassinotti, Andrea, Parravicini, Marco, Chapman, Thomas P., Balzarini, Marco, Canova, Lorenzo, Segato, Simone, Zadro, Valentina, Travis, Simon, Segato, Sergio
Publicado 2023

Broad external validation of a multivariable risk prediction model for gastrointestinal malignancy in iron deficiency anaemia

por Almilaji, Orouba, Webb, Gwilym, Maynard, Alec, Chapman, Thomas P., Shine, Brian S. F., Ellis, Antony J., Hebden, John, Docherty, Sharon, Williams, Elizabeth J., Snook, Jonathon
Publicado 2021

Ataxin-3 Links NOD2 and TLR2 Mediated Innate Immune Sensing and Metabolism in Myeloid Cells

por Chapman, Thomas P., Corridoni, Daniele, Shiraishi, Seiji, Pandey, Sumeet, Aulicino, Anna, Wigfield, Simon, do Carmo Costa, Maria, Thézénas, Marie-Laëtitia, Paulson, Henry, Fischer, Roman, Kessler, Benedikt M., Simmons, Alison
Publicado 2019

Targeted versus universal tuberculosis chemoprophylaxis in 1968 patients with inflammatory bowel disease receiving anti‐TNF therapy in a tuberculosis endemic region

por Ye, Lingna, Chapman, Thomas P., Wen, Zhenzhen, Lin, Lang, Qiu, Yun, Liu, Zhanju, Ran, Zhihua, Qian, Jiaming, Wu, Kaichun, Gao, Xiang, Hu, Pinjin, Chen, Minhu, Travis, Simon P. L., Cao, Qian
Publicado 2020